The House Resolution urges the Louisiana Department of Health to conduct a comprehensive review of factors affecting children diagnosed with autism spectrum disorder (ASD) and their families. The resolution highlights the increasing prevalence of ASD diagnoses, which have risen to one in thirty-six children between 2000 and 2020, and emphasizes the significant health-related conditions often associated with ASD, such as epilepsy, depression, and anxiety. It also points out the economic burden of ASD, estimating lifetime costs at approximately four million dollars per individual, and stresses the need to evaluate environmental factors and toxicants that may contribute to the disorder's prevalence.

The review mandated by the resolution will encompass various aspects, including access to early diagnosis and treatment, education and employment challenges, and the fiscal impact of ASD on individuals and the state's healthcare and education systems. The Louisiana Department of Health is instructed to collaborate with local colleges and universities to leverage clinical expertise in the study. The findings of this review are to be submitted in a written report to the House Committee on Health and Welfare by February 1, 2025, with a focus on identifying regional and demographic prevalence of ASD and potential environmental influences.